BeStock  
Stocks › Medical Devices › DCTH

Delcath Systems DCTH

US equityMarket cap rank #3435Medical Devices
$18.79 −$0.45 (-2.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.50 -1.54%
Open$18.89
Prev close$19.24
Day range$18.51 – $19.35
Volume592.1K
Market cap$653.67M
P/E (TTM)117.4
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$35.10M+70.7% YoY
Operating profit$7.12M+1,934.0% YoY
Net profit$6.95M+737.6% YoY
Diluted EPS$0.17+750.0% YoY
Free cash flow$6.92M+60.4% YoY
Operating cash flow$8.18M

Revenue, last 8 quarters

$15.1MDec '24$19.8MMar '25$24.2MJun '25$20.6MSep '25$20.7MDec '25$25.0MMar '26$29.1MJun '26$35.1MSep '26

Net profit, last 8 quarters

$-3.4MDec '24$1.1MMar '25$2.7MJun '25$830.0KSep '25$-1.9MDec '25$-1.1MMar '26$2.7MJun '26$7.0MSep '26

Diluted EPS by quarter

-0.11Dec '240.03Mar '250.07Jun '250.02Sep '25-0.05Dec '25-0.03Mar '260.07Jun '260.17Sep '26

Free cash flow by quarter

$-1.2MDec '24$2.1MMar '25$6.9MJun '25$4.3MSep '25$7.7MDec '25$287.0KMar '26$5.2MJun '26$6.9MSep '26

Annual revenue

$1.6MFY20$3.6MFY21$2.7MFY22$2.1MFY23$37.2MFY24$85.2MFY25

Profitability & balance sheet

Gross margin87.6%
Operating margin5.2%
Net margin6.1%
Return on equity5.4%
Return on assets4.9%
Return on invested capital5.3%
Current ratio10.87
Liabilities / assets10.4%
Cash & investments$104.32M
Total debt$2.21M
Net cash (debt)$102.10M
Free cash flow / sales18.3%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Hepzato Kit$32.68M 93.1%
  • Chemosat$2.43M 6.9%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $35.10M $29.13M $24.99M $85.23M $20.73M
Total Operating Revenue $35.10M $29.13M $24.99M $85.23M $20.73M
Cost of Revenue $3.92M $2.99M $3.74M $11.80M $3.01M
Gross Profit $31.18M $26.15M $21.26M $73.43M $17.72M
Operating Expense $24.07M $23.75M $22.90M $72.77M $19.90M
Selling and Admin Expenses $13.06M $13.37M $13.07M $43.53M $10.53M
Research & Development $11.01M $10.38M $9.82M $29.25M $9.37M
Operating Profit $7.12M $2.40M -$1.64M $660,000.00 -$2.18M
Net Non-Operating Interest Income (Expense) $852,000.00 $781,000.00 $787,000.00 $2.92M $857,000.00
Non-Operating Interest Income $852,000.00 $781,000.00 $787,000.00 – –
Other Income (Expense) -$1,000.00 -$17,000.00 -$58,000.00 -$70,000.00 -$7,000.00
Other Non-Operating Income (Expenses) -$1,000.00 -$17,000.00 -$58,000.00 -$70,000.00 -$7,000.00
Pretax Profit $7.97M $3.16M -$908,000.00 $3.51M -$1.33M
Tax $1.02M $491,000.00 $162,000.00 $810,000.00 $562,000.00
Net Profit $6.95M $2.67M -$1.07M $2.70M -$1.90M
Profit from Continuing Operations $6.95M $2.67M -$1.07M $2.70M -$1.90M
Net Income to Parent Company $6.95M $2.67M -$1.07M $2.70M -$1.90M
Net Income to Common Stockholders $6.95M $2.67M -$1.07M $2.70M -$1.90M
Basic EPS $0.19 $0.07 -$0.03 $0.08 -$0.05
Diluted EPS $0.17 $0.07 -$0.03 $0.07 -$0.05
Total Other Finance Costs – – – -$2.92M -$857,000.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $149.09M $137.02M $124.84M $123.63M $123.63M
Total Current Assets $141.56M $130.54M $120.27M $119.53M $119.53M
Cash and Cash Equivalents & Short-Term Investments $104.32M $95.90M $89.30M $91.04M $91.04M
-Cash and Cash Equivalents $55.54M $47.52M $41.31M $43.45M $43.45M
-Short Term Investments $48.78M $48.38M $47.99M $47.58M $47.58M
Receivables $20.82M $16.92M $15.26M $12.94M $12.94M
-Accounts Receivable $20.21M $15.94M $14.16M $11.74M $11.74M
-Accrued Interest Receivable $499,000.00 $328,000.00 $581,000.00 $499,000.00 $499,000.00
-Taxes Receivable $102,000.00 $653,000.00 $523,000.00 $696,000.00 $696,000.00
Prepaid Assets $3.37M $3.76M $3.94M $3.76M $3.76M
Inventory $10.50M $11.71M $9.81M $10.25M $10.25M
Other Current Assets $2.55M $2.24M $1.96M $1.55M $1.55M
Total Non-Current Assets $7.54M $6.48M $4.57M $4.10M $4.10M
Net PPE $7.54M $6.48M $4.57M $4.10M $4.10M
-Gross PPE $13.13M $11.93M $9.91M $9.35M $9.35M
-Accumulated Depreciation -$5.60M -$5.45M -$5.34M -$5.25M -$5.25M
Total Liabilities $15.55M $15.87M $12.13M $12.41M $12.41M
Total Current Liabilities $13.02M $13.28M $10.70M $10.95M $10.95M
Payables $3.48M $4.01M $3.46M $2.66M $2.66M
-Accounts Payable $3.48M $4.01M $3.46M $2.66M $2.66M
Current Accrued Expenses $3.60M $4.76M $4.14M $3.55M $3.55M
Short-Term Debt and Capital Lease Obligation $196,000.00 $196,000.00 $92,000.00 $101,000.00 $101,000.00
-Current Capital Lease Obligation $196,000.00 $196,000.00 $92,000.00 $101,000.00 $101,000.00
Total Non-Current Liabilities $2.53M $2.59M $1.43M $1.46M $1.46M
Long Term Debt and Capital Lease Obligation $2.21M $2.27M $815,000.00 $835,000.00 $835,000.00
-Long Term Capital Lease Obligation $2.21M $2.27M $815,000.00 $835,000.00 $835,000.00
Other Non-Current Liabilities $319,000.00 $327,000.00 $615,000.00 $628,000.00 $628,000.00
Total Equity $133.54M $121.15M $112.71M $111.22M $111.22M
Stockholders' Equity $133.54M $121.15M $112.71M $111.22M $111.22M
Capital Stock $348,000.00 $346,000.00 $344,000.00 $347,000.00 $347,000.00
-Common Stock $348,000.00 $346,000.00 $344,000.00 $347,000.00 $347,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $653.12M $647.79M $641.71M $639.15M $639.15M
Retained Earnings -$520.30M -$527.25M -$529.92M -$528.85M -$528.85M
Gains/Losses Not Affecting Retained Earnings $369,000.00 $258,000.00 $571,000.00 $575,000.00 $575,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $8.18M $5.71M $857,000.00 $22.52M $8.25M
Net cash flow from continuing operations $8.18M $5.71M $857,000.00 $22.52M $8.25M
Net Income from Continuing Operations $6.95M $2.67M -$1.07M $2.70M -$1.90M
Depreciation & Depletion & Amortization $285,000.00 $84,000.00 $131,000.00 $349,000.00 $109,000.00
Change in Working Capital -$2.76M -$1.81M -$2.71M -$3.07M $5.98M
-Change in Receivables -$4.27M -$1.78M -$2.42M -$854,000.00 $2.01M
-Change in Inventory $1.21M -$1.91M $444,000.00 -$3.32M $493,000.00
-Change in Prepaid Assets $625,000.00 -$229,000.00 -$423,000.00 -$3.42M $498,000.00
-Change in Payables and Accrued Expense -$258,000.00 $2.51M -$273,000.00 $4.77M $2.97M
-Change in Other Current Liabilities -$64,000.00 -$398,000.00 -$43,000.00 -$241,000.00 $17,000.00
Net cash flow from investing -$1.26M -$504,000.00 -$571,000.00 -$26.59M -$561,000.00
Net Cash Flow from Continuing Investing Activities -$1.26M -$504,000.00 -$571,000.00 -$26.59M -$561,000.00
Net PPE Purchase and Sale -$1.26M -$503,000.00 -$570,000.00 -$1.55M -$550,000.00
Net Investment Purchase and Sale $0.00 -$1,000.00 -$1,000.00 -$25.04M -$11,000.00
Financing Cash Flow $1.10M $962,000.00 -$2.38M $15.05M -$5.94M
Net Cash Flow from Continuing Financing Activities $1.10M $962,000.00 -$2.38M $15.05M -$5.94M
Net Common Stock Issuance -$389,000.00 $378,000.00 -$3.00M -$5.52M -$5.52M
Proceeds from Stock Option Exercised $1.49M $584,000.00 $619,000.00 $20.57M -$425,000.00
Ending Cash Balance $55.54M $47.52M $41.31M $43.45M $43.45M
Net Change in Cash $8.01M $6.17M -$2.10M $10.97M $1.74M
Beginning Cash Balance $47.52M $41.31M $43.45M $32.41M $41.81M
Effect of Exchange Rate Changes $5,000.00 $38,000.00 -$46,000.00 $68,000.00 -$102,000.00
Free Cash Flow $6.92M $5.21M $287,000.00 $20.97M $7.70M
Net Issuance Payments Of Debt – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on DCTH.

Sign in to join the discussion.

Scroll to Top